Skip to main content

Table 1 Association of RBM38 with c-Myc and clinicopathological characteristics of breast cancer

From: The role of c-Myc-RBM38 loop in the growth suppression in breast cancer

Clinicopathological characteristics RBM38 expression
Cases (n) Low (%) High (%) P-value
Age (years) 0.196
<50 66 31 (46.7) 35 (53.3)  
≥50 96 55 (57.3) 41 (42.7)  
Tumor size 0.629
≤2 cm 65 33 (50.8) 32 (49.2)  
˃2 cm 97 53 (54.6) 44 (45.4)  
TNM stage 0.127
I–II 128 64 (63.4) 64 (36.6)  
III 34 22 (87.5) 12 (12.5)  
c-Myc 0.014
Low 108 50 (46.3) 58 (53.7)  
High 54 36 (66.7) 18 (33.3)